搜索并找到您需要的 CMO / CDMO
为您的药物开发和制造项目寻找高技能合作伙伴。
市场: EMA (EU), FDA (USA)
服务: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging
地区: 欧洲
遵守: FDA (cGMP), ISO, IFS, EMA (EU GMP)
批量大小: Large, Small, Medium
类别/产品: 化妆品, 营养保健品, FDF / 药品
使用: Human, Veterinary
OEB（职业暴露带）: 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
OEB（职业暴露带）: 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
市场: EMA (EU), ANVISA (Brazil), Russian Health Authorities, SFDA (Saudi Arabia)
地区: 欧洲
遵守: ISO, Roszdravnadzor (Russia GMP), SFDA (Saudi Food & Drug Authority), EMA (EU GMP)
批量大小: Large, Small, Medium
类别/产品: 化妆品, FDF / 药品
使用: Human, Veterinary
服务: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging
地区: 欧洲
受控物质: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
市场: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), MHRA (UK)
地区: 欧洲
遵守: FDA (cGMP), ISO, EMA (EU GMP)
批量大小: Large, Small, Medium
使用: Human, Veterinary
服务: Development services, Manufacturing services, Analytical / QC services
专业治疗领域 (ATC): (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (N) Nervous system
OEB（职业暴露带）: 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
类别/产品: FDF / 药品
市场: EMA (EU), FDA (USA)
地区: 欧洲
遵守: FDA (cGMP), ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)
批量大小: Large, Small, Medium
类别/产品: 营养保健品, 服务, 粒子工程
使用: Human, Veterinary
BSL（生物安全等级）: 1, 2
服务: Development services, Manufacturing services
OEB（职业暴露带）: 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
受控物质: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
市场: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), Russian Health Authorities, MHRA (UK), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, TGA (Australia)
地区: 欧洲
批量大小: Large, Small, Medium
使用: Human
服务: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging
专业治疗领域 (ATC): (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (A) Digestive tract and metabolism
遵守: PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TGA (Australia GMP), TITCK (Turkish Health Authorities), SFDA (Saudi Food & Drug Authority), EMA (EU GMP), Health Canada (Canada GMP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)
OEB（职业暴露带）: 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
类别/产品: 服务, FDF / 药品
专业治疗领域 (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (A) Digestive tract and metabolism
市场: EMA (EU), NMPA (China), ANVISA (Brazil), Russian Health Authorities, SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities
地区: 欧洲
批量大小: Large
使用: Human
BSL（生物安全等级）: 1
服务: Manufacturing services, Analytical / QC services, Regulatory services, Packaging
受控物质: Lowest potential for abuse
遵守: ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TITCK (Turkish Health Authorities), SFDA (Saudi Food & Drug Authority), NMPA (China GMP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)
类别/产品: FDF / 药品
OEB（职业暴露带）: 1 / low-hazard (PDE > 10,000 µg/day)
受控物质: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
市场: EMA (EU), PMDA (Japan), NMPA (China), MHRA (UK), MFDS (South Korea)
服务: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
地区: 欧洲
批量大小: Large, Small, Medium
使用: Human, Veterinary
OEB（职业暴露带）: 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
遵守: EMA (EU GMP)
类别/产品: FDF / 药品
受控物质: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
市场: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), ANVISA (Brazil), MHRA (UK), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), TGA (Australia)
服务: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
地区: 欧洲
遵守: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), TGA (Australia GMP), TITCK (Turkish Health Authorities), UAE Ministry of Health & Prevention, NMPA (China GMP), EMA (EU GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP), NSF
批量大小: Large, Small, Medium
使用: Human
专业治疗领域 (ATC): (D) Dermatologicals, (V06) Nutrients, (A) Digestive tract and metabolism
OEB（职业暴露带）: 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
类别/产品: FDF / 药品
OEB（职业暴露带）: 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
受控物质: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
市场: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), ANMAT (Argentina), SFDA (Saudi Arabia), MFDS (South Korea), EDE (UAE), CDSCO (India), TGA (Australia)
服务: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
地区: 欧洲
遵守: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), UAE Ministry of Health & Prevention, NMPA (China GMP), EMA (EU GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP), NSF
批量大小: Large, Small, Medium
使用: Human
类别/产品: 服务, FDF / 药品
受控物质: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
市场: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), MHRA (UK), SFDA (Saudi Arabia), MFDS (South Korea), EDE (UAE), CDSCO (India), TGA (Australia)
服务: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
地区: 亚太地区
遵守: FDA (cGMP), PMDA/MHLW (Japan GMP), EMA (EU GMP)
批量大小: Large
使用: Human
OEB（职业暴露带）: 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
类别/产品: 服务, FDF / 药品
市场: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), MHRA (UK), MFDS (South Korea)
服务: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
地区: 欧洲
遵守: FDA (cGMP), EMA (EU GMP)
使用: Human
受控物质: High potential for abuse & no medical use
批量大小: Small, Medium
OEB（职业暴露带）: 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
类别/产品: FDF / 药品